Immunogenic cell stress and death

G Kroemer, C Galassi, L Zitvogel, L Galluzzi - Nature immunology, 2022 - nature.com
Dying mammalian cells emit numerous signals that interact with the host to dictate the
immunological correlates of cellular stress and death. In the absence of reactive antigenic …

The hallmarks of cancer immune evasion

C Galassi, TA Chan, I Vitale, L Galluzzi - Cancer Cell, 2024 - cell.com
According to the widely accepted" three Es" model, the host immune system eliminates
malignant cell precursors and contains microscopic neoplasms in a dynamic equilibrium …

Cytosolic DNA‐STING‐NLRP3 axis is involved in murine acute lung injury induced by lipopolysaccharide

L Ning, W Wei, J Wenyang, X Rui… - Clinical and …, 2020 - Wiley Online Library
The role of NOD‐like receptor protein 3 (NLRP3)‐mediated pyroptosis in acute lung injury
(ALI) has been well identified previously. Stimulator of interferon genes (STING) is an …

Cellular pathways influenced by protein arginine methylation: Implications for cancer

J Xu, S Richard - Molecular cell, 2021 - cell.com
Arginine methylation is an influential post-translational modification occurring on histones,
RNA binding proteins, and many other cellular proteins, affecting their function by altering …

PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity

J Liu, X Bu, C Chu, X Dai, JM Asara, P Sicinski… - Nature …, 2023 - nature.com
Activation of the cGAS/STING innate immunity pathway is essential and effective for anti-
tumor immunotherapy. However, it remains largely elusive how tumor-intrinsic cGAS …

[HTML][HTML] PRMT5 function and targeting in cancer

H Kim, AR Ze'ev - Cell stress, 2020 - ncbi.nlm.nih.gov
Protein methyl transferases play critical roles in numerous regulatory pathways that underlie
cancer development, progression and therapy-response. Here we discuss the function of …

Targeting arginine methyltransferase PRMT5 for cancer therapy: updated progress and novel strategies

J Zheng, B Li, Y Wu, X Wu, Y Wang - Journal of Medicinal …, 2023 - ACS Publications
As a predominant type II protein arginine methyltransferase, PRMT5 plays critical roles in
various normal cellular processes by catalyzing the mono-and symmetrical dimethylation of …

[HTML][HTML] Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance

Y Zhu, T Xia, DQ Chen, X Xiong, L Shi, Y Zuo… - Drug Resistance …, 2024 - Elsevier
Drug resistance remains a major challenge in cancer treatment, necessitating the
development of novel strategies to overcome it. Protein arginine methyltransferases …

Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy

M Redondo-Muñoz, FJ Rodriguez-Baena, P Aldaz… - Nature …, 2023 - nature.com
Resistance of melanoma to targeted therapy and immunotherapy is linked to metabolic
rewiring. Here, we show that increased fatty acid oxidation (FAO) during prolonged BRAF …

Protein arginine methyltransferase 5 (PRMT5) inhibitors in oncology clinical trials: a review

K Feustel, GS Falchook - Journal of Immunotherapy and …, 2022 - meridian.allenpress.com
ABSTRACT Protein arginine methyltransferase 5 (PRMT5) inhibitors are a new class of
antineoplastic agents showing promising preliminary clinical efficacy. Targeting an enzyme …